Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Valipour (Wien, Austria), S. Avdeev (Moscow, Russian Federation), A. Barczyk (Katowice, Poland), V. Bayer (Ridgefield, United States of America), Z. Fridlender (Jerusalem, Israel), M. Georgieva (Vidin, Bulgaria), O. Kudela (Hradec Králové, Czech Republic), A. Medvedchikov (Wien, Austria), R. Miron (Iasi, Romania), M. Sanzharovskaya (Wien, Austria), V. Šileikiene (Vilnius, Lithuania), J. Šorli (Topolšica, Slovenia), M. Spielmanns (Wald, Switzerland), Z. Szalai (Gyor, Hungary). Late Breaking Abstract - Real-world evidence of dual bronchodilator therapy using Clinical COPD Questionnaire in 4700 COPD patients. 5231

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Assessment of physical functioning and handling with Tiotropium/Olodaterol (T/O) in patients with COPD requiring long-acting dual bronchodilation in an Italian cohort of patients. Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Late Breaking Abstract - Difference in clinical outcomes between smoking and non-smoking asthma patients who initiated an ICS or ICS/LABA treatment Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Prescribing patterns for UK patients commencing first maintenance therapy for COPD Source: International Congress 2014 – COPD markers Year: 2014 Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Late Breaking Abstract - Impact of ICS/LABA and LABA/LAMA FDCs on lung function and exacerbation of COPD: a network meta-analysis Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Evaluating cardiac safety of tiotropium in patients with COPD: Combined analysis of Holter-ECG data from four trials Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Late Breaking Abstract - Factors associated with health-status of COPD patients on Dry Powder Inhaler (DPI) maintenance therapy Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Analyzing the pathway to triple therapy in COPD patients: A retrospective database analysis Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Late Breaking Abstract - Extrafine single inhaler triple therapy improves quality of life in COPD. Analysis of SGRQ subdomains of the TRIBUTE Study Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018 Pharmacological treatment of COPD in the on-sint cohort Source: International Congress 2014 – COPD exacerbations Year: 2014 One-year efficacy of aclidinium/formoterol fixed-dose combination in COPD patients: The AUGMENT COPD study Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 What are common COPD symptoms in a real-life setting? The German DACCORD registry Source: International Congress 2014 – COPD markers Year: 2014 Preference, satisfaction and critical errors with Genuair® and Breezhaler® in patients with COPD Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis Source: International Congress 2014 – COPD exacerbations Year: 2014 Clinical trials for elderly patients with multiple diseases (CHROMED): A pilot study Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes Source: International Congress 2014 – Markers Year: 2014 Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019